Table 4.
Trans-18:2 intake | Trans-18:1 intake | |||
---|---|---|---|---|
Multivariate-adjusted difference (95%CI) in each HRV index for each 1 SD (0.06 g/d) higher consumption of trans-18:2 fatty acids* | p | Multivariate-adjusted difference (95%CI) in each HRV index for each 1 SD (0.68 g/d) higher consumption of trans-18:1 fatty acids* | p | |
Resting Heart Rate, bpm (N=529) † | +3.88 (−0.10, 7.86) | 0.06 | −4.11 (−8.18, −0.44) | 0.05 |
| ||||
Time-domain HRV (N=578) | ||||
SDNN, ms | −15% (−25, −4) | 0.009 | +19% (5, 34) | 0.007 |
SDANN, ms | −15% (−25, −3) | 0.02 | +19% (5, 36) | 0.009 |
SDNNindex, ms | −14% (−25, −1) | 0.03 | +15% (1, 32) | 0.04 |
rMSSD, ms‡ | −10% (−36, 11) | 0.34 | +12% (−9, 38) | 0.26 |
Frequency-domain HRV (544) | ||||
TP, ms2 | −30% (−46, −10) | 0.005 | +44% (11, 86) | 0.006 |
ULF, ms2 | −30% (−47, −9) | 0.008 | +45% (11, 90) | 0.007 |
VLF, ms2 | −23 (−41, 2) | 0.07 | +24% (−7, 64) | 0.14 |
LF/HF, ratio | 10% (−12, 38) | 0.38 | −7% (−26, 17) | 0.56 |
LFnu, %†‡ | 0.69 (−2.66, 4.04) | 0.68 | −0.04 (−3.46, 3.38) | 0.98 |
HFnu, %†‡ | −1.37 (−4.22, 1.48) | 0.34 | +1.14 (−1.77, 4.04) | 0.77 |
Non-linear HRV (N=544) | ||||
DFA1† | +0.01 (−0.07, 0.09) | 0.79 | −0.005 (−0.09, 0.08) | 0.90 |
SD12 | −3% (−17, 7) | 0.57 | +3% (−8, 18) | 0.60 |
See Legend Table 3.
rMSSD, nuLF, and nuHF were evaluated among individuals with lower erratic HRV (DFA> median; n=345). R-squared values are the following: 0.15 (resting HR); 0.12 (SDNN); 0.11 (SDANN); 0.12 (SDNNindex); 0.16(rMSSD); 0.13 (TP); 0.12 (ULF); 0.17 (VLF); 0.16 (LF/HF ratio); 0.15(LFnu); 0.18 (HFnu); 0.17 (DFA1); 0.13 (SD12).